129 related articles for article (PubMed ID: 31485598)
1. HBV triggers APOBEC2 expression through miR‑122 regulation and affects the proliferation of liver cancer cells.
Li A; Wu J; Zhai A; Qian J; Wang X; Qaria MA; Zhang Q; Li Y; Fang Y; Kao W; Song W; Zhang Z; Zhang F
Int J Oncol; 2019 Nov; 55(5):1137-1148. PubMed ID: 31485598
[TBL] [Abstract][Full Text] [Related]
2. Excessive activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide 2 (APOBEC2) contributes to liver and lung tumorigenesis.
Okuyama S; Marusawa H; Matsumoto T; Ueda Y; Matsumoto Y; Endo Y; Takai A; Chiba T
Int J Cancer; 2012 Mar; 130(6):1294-301. PubMed ID: 21469143
[TBL] [Abstract][Full Text] [Related]
3. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
[TBL] [Abstract][Full Text] [Related]
4. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.
Feng J; Yang G; Liu Y; Gao Y; Zhao M; Bu Y; Yuan H; Yuan Y; Yun H; Sun M; Gao H; Zhang S; Liu Z; Yin M; Song X; Miao Z; Lin Z; Zhang X
Theranostics; 2019; 9(18):5227-5245. PubMed ID: 31410212
[No Abstract] [Full Text] [Related]
6. Expression of Plasma hsa-miR122 in HBV-Related Hepatocellular Carcinoma (HCC) in Vietnamese Patients.
Quoc NB; Phuong NDN; Ngan TK; Linh NTM; Cuong PH; Chau NNB
Microrna; 2018; 7(2):92-99. PubMed ID: 29701140
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
[TBL] [Abstract][Full Text] [Related]
8. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.
Li Z; Ma L; Di L; Lin X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760167
[TBL] [Abstract][Full Text] [Related]
10. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Gao F; Sun X; Wang L; Tang S; Yan C
Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
[TBL] [Abstract][Full Text] [Related]
14. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
Wang CM; Wang Y; Fan CG; Xu FF; Sun WS; Liu YG; Jia JH
Biochem Biophys Res Commun; 2011 Aug; 411(3):586-92. PubMed ID: 21763284
[TBL] [Abstract][Full Text] [Related]
15. HBx‑associated long non‑coding RNA activated by TGF‑β promotes cell invasion and migration by inducing autophagy in primary liver cancer.
Zhang Y; Li J; Wang S; Yang F; Zhou Y; Liu Y; Zhu W; Shi X
Int J Oncol; 2020 Jan; 56(1):337-347. PubMed ID: 31746419
[TBL] [Abstract][Full Text] [Related]
16. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
Lamontagne J; Steel LF; Bouchard MJ
World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
[TBL] [Abstract][Full Text] [Related]
18. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
[TBL] [Abstract][Full Text] [Related]
19. Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3.
Li X; Yuan M; Song L; Wang Y
BMC Med Genet; 2020 Mar; 21(1):48. PubMed ID: 32138690
[TBL] [Abstract][Full Text] [Related]
20. Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis.
Zhang Y; Chen X; Cao Y; Yang Z
Bioengineered; 2021 Dec; 12(1):2074-2086. PubMed ID: 34043485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]